ரோச் மூலக்கூறு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ரோச் மூலக்கூறு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ரோச் மூலக்கூறு Today - Breaking & Trending Today

Alveo Technologies Appoints Veteran Biotech and Diagnostics Leader to Board of Directors


Alveo Technologies Appoints Veteran Biotech and Diagnostics Leader to Board of Directors
Roche executive Neil Gunn brings quarter-century of commercialization experience to infectious disease testing innovator
News provided by
Share this article
Share this article
ALAMEDA, Calif., May 13, 2021 /PRNewswire/ Alveo Technologies, Inc., an infectious disease testing leader, announced today biotechnology, diagnostics and medical device executive Neil Gunn has accepted an appointment to its board of directors.
To download a photo of Neil Gunn, click here.
Gunn, the retired president of Roche Sequencing Solutions, and current CEO of IDbyDNA, brings more than 25 years of healthcare industry experience to Alveo, with comprehensive knowledge and experience managing global product development, strategy development and commercial operations.  ....

United Kingdom , Neil Gunn , Ron Chiarello , Nottingham Trent University , Prnewswire Alveo Technologies Inc , Roche Sequencing Solutions , Drug Administration , Pall Medical Ltd , Portsmouth University , Global Business , Roche Molecular , Roche Sequencing , Novartis Diagnostics , Marine Microbiology , Nottingham Trent , Emergency Use Authorization , Alveo Technologies , ஒன்றுபட்டது கிஂக்டம் , நீல் துப்பாக்கி , ரோன் சியாரெல்லோ , நாட்டிங்ஹாம் ட்ரெண்ட் பல்கலைக்கழகம் , ரோச் வரிசைப்படுத்துதல் தீர்வுகள் , போரதிஸ்மௌத் பல்கலைக்கழகம் , உலகளாவிய வணிக , ரோச் மூலக்கூறு , ரோச் வரிசைப்படுத்துதல் ,

Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce


A total of 2165 unvaccinated employees and 3052 vaccinated employees were included. A, Any SARS-CoV-2 infection among St Jude employees during follow-up. B, Asymptomatic infections identified through routine asymptomatic screening; SARS-CoV-2 cases through testing based on the presence of symptoms or known COVID-19 exposure were treated as competing risks. C, Positive results via testing based on the presence of symptoms or known COVID-19 exposure; positive results from asymptomatic screening were treated as competing risks. Shaded areas are 95% CIs.
Table.  Estimated Incidence Rate Ratio Against Any SARS-CoV-2 Infection and Asymptomatic or Symptomatic/Contact SARS-CoV-2 Infection
a
1.
Polack
 FP, Thomas
 SJ, Kitchin
 N,
 et al; C4591001 Clinical Trial Group.  Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine.  ....

Yilun Sun , Motomi Mori , Kari Lahmon , Greg Armstrong , Li Tang , Jodyw Zylke , Sandra Dennis , Rehana Hakim , St Jude Children Research Hospital , Nursing Administration , Department Of Biostatistics , American Lebanese Syrian Associated Charities , Quidel Corporation , Research Hospital , Mail Stop , Interest Disclosures , Roche Molecular , Human Resources , Richard Webby , Infectious Diseases , Cancer Control , Sri Suganda , கிரெக் ஆம்ஸ்ட்ராங் , லி டாங் , சாண்ட்ரா டென்னிஸ் , ஹனா ஹக்கீம் ,